Topical Questions — House of Commons, 2022-03-01
Topic: Health
Questions: I welcome the record funding that is going into our NHS and also the plans to catch up with appointments and treatments that were delayed because of the covid-19 pandemic. Can my right hon. Friend say a little bit more about how he will increase the number of face-to-face GP appointments available to my Crawley constituents and, indeed, people across the country?; Devon’s community hospitals and minor injury units, such as the Tyrrell in Ilfracombe, have been unable to open fully for some time. Would my hon. Friend consider extra help where it is needed to enable them to reopen, because although adding extra capacity is welcome, using what we have effectively is surely essential?; Happy St David’s day, Mr Speaker. Physician associates in my constituency, who play a vital role in the NHS, want to hear from the Government when long-awaited regulations that will allow them to take on more responsibility and play an even greater role in our NHS will come forward. Can the Secretary of State update the House and will he meet me and constituents to discuss this?; I recently met Specsavers to discuss how patient choice should be promoted by making all routine community services patient self-referrals, especially when that can free up GPs’ time by not using them as administrative gatekeepers. Will the Secretary of State commit to meeting me to discuss how we can increase GP capacity using such measures?;   Dydd Gŵyl Dewi hapus to you, Mr Speaker, and the whole House. The Minister should be aware of my long-fought campaign to improve how IVF add-ons are marketed to people who are longing for a baby. These add-ons, such as embryo glue or assisted hatching, often have limited success rates and cost thousands of pounds on top of an already expensive procedure. The system simply needs more regulation, so will she commit to meeting me to discuss this important issue further?; I thank the Secretary of State for the extremely welcome news that he will introduce a licensing regime for non-surgical cosmetic interventions. This is a huge step forward for women’s health, and one that I have campaigned for over many years, along with many across the House. I am absolutely delighted. Can he inform us how the proposed licensing regime will keep pace with the rapidly changing landscape of these treatments?; The response from the hon. Member for Lewes (Maria Caulfield) to the question from my right hon. Friend the Member for Kingston upon Hull North (Dame Diana Johnson) on health inequalities gives me no confidence that the Government have a plan to address these inequalities at all. She says that we have had a pandemic—of course we have, but the point is that it has happened everywhere. What does it say about this Government’s priorities that waiting times are escalating to a far greater extent in more deprived communities than they are in the more affluent communities that the Tories are so happy to represent?; According to the Royal College of Obstetricians and Gynaecologists, less than 3% of medical research funding in the UK is focused on women-specific diseases such as endometriosis and polycystic ovary syndrome. They are serious conditions, but too little is known about them and we do not hear enough about them, especially polycystic ovary syndrome. The failure to increase research funding is holding back women’s outcomes and experiences. What are the UK Government doing to increase the priority given to research funding for both those conditions?
Sajid Javid (Conservative, Centre-right): The hon. Gentleman will know that for medicines to be generally available on the NHS, they have to be deemed safe and effective by the independent medical regulator. That requires trials to take place and that is where the focus should be. Those who want those medicines to be more easily available should encourage the companies that produce them to have trials and the NHS will support them in doing so.